CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-30 | Meyers Michael L. SVP, Chief Medical Officer | Option exercise | +5,900 | $8.77 | $52K | 21,566 |
| 2021-12-30 | Meyers Michael L. SVP, Chief Medical Officer | Option exercise · Stock Options (Right to buy) | −5,900 | 0 | ||
| 2021-12-22 | Legault Pierre Director | Option exercise | +24,000 | $7.88 | $189K | 40,000 |
| 2021-12-22 | Legault Pierre Director | Sale | −24,000 | $22.01 | $528K | 16,000 |
| 2021-12-22 | Legault Pierre Director | Option exercise · Stock Options (Right to buy) | −24,000 | 0 | ||
| 2021-12-20 | Legault Pierre Director | Option exercise | +20,000 | $7.08 | $142K | 36,000 |
| 2021-12-20 | Legault Pierre Director | Sale | −20,000 | $21.01 | $420K | 16,000 |
| 2021-12-20 | Legault Pierre Director | Option exercise · Stock Options (Right to buy) | −20,000 | 0 | ||
| 2021-12-20 | Metzger Michael A President and COO | Option exercise | +16,000 | $6.38 | $102K | 33,659 |
| 2021-12-20 | Metzger Michael A President and COO | Sale | −16,000 | $20.29 | $325K | 17,659 |
| 2021-12-20 | Metzger Michael A President and COO | Option exercise | +45,000 | $8.77 | $395K | 62,659 |
| 2021-12-20 | Metzger Michael A President and COO | Sale | −45,000 | $20.29 | $913K | 17,659 |
| 2021-12-20 | Metzger Michael A President and COO | Option exercise · Stock Options (Right to buy) | −45,000 | 0 | ||
| 2021-12-20 | Metzger Michael A President and COO | Option exercise · Stock Options (Right to buy) | −16,000 | 0 | ||
| 2021-12-17 | Morrison Briggs Chief Executive Officer | Option exercise | +35,156 | $10.90 | $383K | 83,492 |
| 2021-12-17 | Morrison Briggs Chief Executive Officer | Sale | −35,156 | $20.00 | $703K | 48,336 |
| 2021-12-17 | Morrison Briggs Chief Executive Officer | Option exercise · Stock Options (Right to buy) | −35,156 | 0 | ||
| 2021-12-17 | Metzger Michael A President and COO | Option exercise | +1,676 | $6.38 | $11K | 19,335 |
| 2021-12-17 | Metzger Michael A President and COO | Sale | −1,676 | $19.02 | $32K | 17,659 |
| 2021-12-17 | Metzger Michael A President and COO | Option exercise · Stock Options (Right to buy) | −1,676 | 0 |
Page 16 of 25 · 500 trades